Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2178-2180
Published online before print April 28, 2003, doi: 10.1161/01.CIR.0000070592.04766.36
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
107/17/2178    most recent
01.CIR.0000070592.04766.36v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colombo, A.
Right arrow Articles by Di Mario, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, A.
Right arrow Articles by Di Mario, C.
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary interventions: stents

(Circulation. 2003;107:2178.)
© 2003 American Heart Association, Inc.


Brief Rapid Communications

Preliminary Observations Regarding Angiographic Pattern of Restenosis After Rapamycin-Eluting Stent Implantation

Antonio Colombo, MD; Dejan Orlic, MD; Goran Stankovic, MD; Nicola Corvaja, MD; Vassilis Spanos, MD; Matteo Montorfano, MD; Francesco Liistro, MD; Mauro Carlino, MD; Flavio Airoldi, MD; Alaide Chieffo, MD; Carlo Di Mario, MD, PhD

From Columbus Hospital (A.C., D.O., G.S., N.C., V.S., C.D.M.) and San Raffaele Hospital (A.C., M.M., F.L., M.C., F.A., C.D.M.), Milan, Italy.

Correspondence to Antonio Colombo, MD, EMO Centro Cuore Columbus, Via M. Buonarroti 48, 20145, Milan, Italy. E-mail info{at}emocolumbus.it

Background— Restenosis after implantation of drug-eluting stents (DES) is a rare phenomenon, occurring more frequently peri-stent.

Methods and Results— We evaluated the pattern of restenosis occurring after implantation of DES in unselected lesions. From April 15 to December 6, 2002, we treated 368 patients with 735 lesions by using 841 rapamycin-eluting stents (Cypher, Cordis, a Johnson & Johnson Company). Mean baseline lesion length was 17.48±12.19 mm, and mean stent length was 27.59±14.02 mm. Follow-up ischemia-driven angiography was performed in 24 patients. Eleven patients had angiographic restenosis (>=50% diameter stenosis) in 14 stented segments (stent and 5 mm proximal and distal to the stent). The pattern of restenosis in all 14 stented segments was focal, and in 6 of them it was multifocal, occurring inside the stents. Mean length of restenotic lesions was 5.62±1.90 mm, with a range from 2.54 to 8.44 mm. One multifocal restenosis involved also the distal stent margin. Intravascular ultrasound evaluation at follow-up, performed in 2 patients, showed significant lumen obstruction attributable to in-stent hyperplasia in both cases. Individual cases can be viewed in the Data Supplement.

Conclusions— The pattern of restenotic lesions after rapamycin-eluting stent implantation was focal and mostly inside the stent.


Key Words: restenosis • stents • angiography




This article has been cited by other articles:


Home page
Circ Cardiovasc IntervHome page
C. E. Appleby, J. Ivanov, S. Lavi, K. Mackie, E. M. Horlick, D. Ing, C. B. Overgaard, P. H. Seidelin, R. von Harsdorf, and V. Dzavik
The Adverse Long-Term Impact of Renal Impairment in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era
Circ Cardiovasc Interv, August 1, 2009; 2(4): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
A. D. Frutkin, J. B. Lindsey, S. K. Mehta, J. A. House, J. A. Spertus, D. J. Cohen, J. S. Rumsfeld, S. P. Marso, and on behalf of the NCDR (National Cardiovascular Dat
Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization: Analysis From the NCDR (National Cardiovascular Data Registry)
J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 614 - 621.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
C. Di Mario, G. R. Heyndrickx, F. Prati, and N. H.J. Pijls
CHAPTER 8 Invasive Imaging and Haemodynamics
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave, L. Buellesfeld, E. Bonizzoni, M. Carlino, U. Gerckens, C. Godino, et al.
Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment
Circulation, August 14, 2007; 116(7): 745 - 754.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. di Mario and K. Dimopoulos
The Effect of Drug-Eluting Stents on Collateral Coronary Flow
J. Am. Coll. Cardiol., August 7, 2007; 50(6): 560 - 560.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. J. Corbett, J. Cosgrave, G. Melzi, R. Babic, G. G.L. Biondi-Zoccai, C. Godino, N. Morici, F. Airoldi, I. Michev, M. Montorfano, et al.
Patterns of restenosis after drug-eluting stent implantation: insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents
Eur. Heart J., October 1, 2006; 27(19): 2330 - 2337.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Cosgrave, G. Melzi, G. G.L. Biondi-Zoccai, F. Airoldi, A. Chieffo, G. M. Sangiorgi, M. Montorfano, I. Michev, M. Carlino, E. Bonizzoni, et al.
Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome
J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2399 - 2404.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M.-K. Hong, G. S. Mintz, C. W. Lee, D.-W. Park, B.-R. Choi, K.-H. Park, Y.-H. Kim, S.-S. Cheong, J.-K. Song, J.-J. Kim, et al.
Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation
Eur. Heart J., June 1, 2006; 27(11): 1305 - 1310.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Chieffo, N. Morici, F. Maisano, E. Bonizzoni, J. Cosgrave, M. Montorfano, F. Airoldi, M. Carlino, I. Michev, G. Melzi, et al.
Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience
Circulation, May 30, 2006; 113(21): 2542 - 2547.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Wessely, A. Schomig, and A. Kastrati
Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting Stents: Similar But Different
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al.
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 216 - 235.
[Full Text] [PDF]


Home page
CirculationHome page
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al.
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
Circulation, January 3, 2006; 113(1): 156 - 175.
[Full Text] [PDF]


Home page
HeartHome page
E Iofina, P W Radke, P Skurzewski, P K Haager, R Blindt, K-C Koch, P Hanrath, J vom Dahl, and R Hoffmann
Superiority of sirolimus eluting stent compared with intracoronary {beta} radiation for treatment of in-stent restenosis: a matched comparison
Heart, December 1, 2005; 91(12): 1584 - 1589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. V. Finn, F. D. Kolodgie, J. Harnek, L.J. Guerrero, E. Acampado, K. Tefera, K. Skorija, D. K. Weber, H. K. Gold, and R. Virmani
Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents
Circulation, July 12, 2005; 112(2): 270 - 278.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Ge, I. Iakovou, J. Cosgrave, A. Chieffo, M. Montorfano, I. Michev, F. Airoldi, M. Carlino, G. Melzi, G. M. Sangiorgi, et al.
Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions
Eur. Heart J., June 1, 2005; 26(11): 1056 - 1062.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Tsagalou, A. Chieffo, I. Iakovou, L. Ge, G. M. Sangiorgi, N. Corvaja, F. Airoldi, M. Montorfano, I. Michev, and A. Colombo
Multiple Overlapping Drug-Eluting Stents to Treat Diffuse Disease of the Left Anterior Descending Coronary Artery
J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1570 - 1573.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, et al.
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
JAMA, May 4, 2005; 293(17): 2126 - 2130.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Costa and D. I. Simon
Molecular Basis of Restenosis and Drug-Eluting Stents
Circulation, May 3, 2005; 111(17): 2257 - 2273.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Ge, I. Iakovou, G. M. Sangiorgi, A. Chieffo, G. Melzi, J. Cosgrave, M. Montorfano, I. Michev, F. Airoldi, M. Carlino, et al.
Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Iakovou, T. Schmidt, L. Ge, G. M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, et al.
Angiographic patterns of restenosis after paclitaxel-eluting stent implantation
J. Am. Coll. Cardiol., March 1, 2005; 45(5): 805 - 806.
[Full Text] [PDF]


Home page
CirculationHome page
A. Chieffo, G. Stankovic, E. Bonizzoni, E. Tsagalou, I. Iakovou, M. Montorfano, F. Airoldi, I. Michev, M. G. Sangiorgi, M. Carlino, et al.
Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main
Circulation, February 15, 2005; 111(6): 791 - 795.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Takebayashi, G. S. Mintz, S. G. Carlier, Y. Kobayashi, K. Fujii, T. Yasuda, R. A. Costa, I. Moussa, G. D. Dangas, R. Mehran, et al.
Nonuniform Strut Distribution Correlates With More Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation
Circulation, November 30, 2004; 110(22): 3430 - 3434.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Lemos, N. Mercado, R. T. van Domburg, R. E. Kuntz, W. W. O'Neill, and P. W. Serruys
Comparison of Late Luminal Loss Response Pattern After Sirolimus-Eluting Stent Implantation or Conventional Stenting
Circulation, November 16, 2004; 110(20): 3199 - 3205.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Saia, P A Lemos, C A Arampatzis, A Hoye, M Degertekin, K Tanabe, G Sianos, P C Smits, W J van der Giessen, P J de Feyter, et al.
Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry
Heart, October 1, 2004; 90(10): 1183 - 1188.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G W Mikhail, F Airoldi, D Tavano, A Chieffo, R Rogacka, M Carlino, M Montorfano, G Sangiorgi, N Corvaja, I Michev, et al.
The use of drug eluting stents in single and multivessel disease: results from a single centre experience
Heart, September 1, 2004; 90(9): 990 - 994.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Chieffo, E. Bonizzoni, D. Orlic, G. Stankovic, R. Rogacka, F. Airoldi, G. W. Mikhail, M. Montorfano, I. Michev, M. Carlino, et al.
Intraprocedural Stent Thrombosis During Implantation of Sirolimus-Eluting Stents
Circulation, June 8, 2004; 109(22): 2732 - 2736.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Lemos, C. A.G. van Mieghem, C. A. Arampatzis, A. Hoye, A. T.L. Ong, E. McFadden, G. Sianos, W. J. van der Giessen, P. J. de Feyter, R. T. van Domburg, et al.
Post-Sirolimus-Eluting Stent Restenosis Treated With Repeat Percutaneous Intervention: Late Angiographic and Clinical Outcomes
Circulation, June 1, 2004; 109(21): 2500 - 2502.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
P. H Chong and J. W. Cheng
Early Experiences and Clinical Implications of Restenosis and Drug-Eluting Stents: Part 2
Ann. Pharmacother., May 1, 2004; 38(5): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. W. O'Neill and S. R. Dixon
The year in interventional cardiology
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 875 - 890.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
V Bhatia, R Bhatia, and M Dhindsa
Drug-eluting stents: new era and new concerns
Postgrad. Med. J., January 1, 2004; 80(939): 13 - 18.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. O. Cheng, A. Colombo, D. Orlic, G. Stankovic, N. Corvaja, V. Spanos, M. Montorfano, F. Liistro, M. Carlino, F. Airoldi, et al.
The SIRIUS Trial Is Not a Sirius Trial * Response
Circulation, November 11, 2003; 108 (19): e137 - e137.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Restenosis Pattern with Drug-Eluting Stents
Journal Watch Cardiology, July 25, 2003; 2003(725): 3 - 3.
[Full Text]